Collplant Biotechnologies Ltd (CLGN) Directors and Executive Officers

Officers & Directors

Yehiel Tal, age 73, serves as Chief Executive Officer and Interim Chairman of the Board. He has over 30 years of management experience in the Israeli and American high-tech and biotechnology sectors. His previous roles include CEO and co-founder of Regentis Biomaterials Ltd., Vice President of Business Development at ProChon BioTech Ltd., Vice President of Marketing and Business Development at OrthoScan Technologies Ltd., and Director of Business Development and Business Unit Manager at Kulicke and Soffa Industries, Inc. He holds a Bachelor's and Master's degree in Mechanical Engineering from the Technion, Israel Institute of Technology. Eran Rotem, CPA, age 58, is Deputy CEO and Chief Financial Officer. He has 30 years of financial and operational experience, having served as CFO of Tefron Ltd., Healthcare Technologies Ltd., and Gamida Ltd., and as a senior manager at Ernst & Young. He holds a Bachelor's degree in Accounting and Business Administration from the Tel Aviv College of Management and is a Certified Public Accountant in Israel. Oren Fahimipoor, age 44, has been Vice President of Operations since April 2, 2023. He has over 15 years of experience in biopharmaceutical operations, previously serving as Business Unit Manager at Omrix Biopharmaceuticals, a Johnson & Johnson company, and holding several positions at Teva Pharmaceuticals. He holds a Bachelor of Science in Biotechnology Engineering from Ben Gurion University and an MBA from the Open University of Israel. Dr. Philippe Bensimon, age 60, has been Vice President of Regulatory Affairs and Quality Assurance since February 2011. He has over 30 years of experience in regulatory affairs, quality assurance, and clinical affairs. His prior roles include Director at InterVascular Datascope (now Maquet-Getinge Group) and Manager at 3M Medical.

Collplant Biotechnologies Ltd currently has 39 employees.